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Introduction
Germ cell tumor (GCT) is an abnormal tissue 
development from primordial germ cell 
that has various clinical manifestations and 
histopathology. Normally, this primordial germ 
cell can arise in the ovarium and testicle,1,2 as 
well as in the extragonadal sites including the 
mediastinum, intracranial, and sacrococcygeal. 
Most of the patients have intragonadal 
GCT.3 This tumor has numerous histological 
subtypes. The clinical manifestations vary 
with tumor site, histologic subtypes, and 
stages. The main manifestations of GCT are 
abdominal pain, abdominal distention, and 
palpable mass at the site of the tumor.4 Other 
manifestations are weight loss and precocious 
puberty.1
This tumor can be benign or malignant. 
Three-percent of malignancy in pediatric aged 
0–8 is occupied by GCT and the incidence 
increase by 15% during adolescence.3 GCT is 
more common in girls with an incidence of 5.3 
per million in girls and 4.3 per million in boys.5 
Epidemiological study has shown that Asian 
countries have the highest incidence of GCT, 
including Indonesia.6 Five-years survival rate 
of this tumor is 98% in the earlier stage and 
80% for the malignant tumor.3
Currently, the study reporting clinical 
manifestations of pediatric GCT patients 
in Indonesia is still limited. This study 
aimed to gather information about clinical 
manifestations among pediatric GCT patients 
in Dr. Hasan Sadikin General Hospital, a top 
referral hospital in West Java. Furthermore, 
the outcome of the GCT treatment was 
explored. It is expected that knowing these 
approaches will help clinicians to get a proper 
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Abstract
Background: Germ cell tumor (GCT) occurs in 3% of pregnancy malignancies and increases by 15% 
during adolescence. In developing countries, the five-year survival rate is 98% and 80% for GCT 
earlier stage and malignant tumor, respectively. This study aimed to gather information about clinical 
manifestations of GCT and to evaluate the treatment outcome in pediatric GCT patients at Dr. Hasan 
Sadikin General Hospital, Bandung, Indonesia.
Methods: A descriptive cross-sectional study design with a total sampling method was conducted 
using secondary data from the medical record of pediatric patients diagnosed with GCT from 2015 
to 2018. Data on nutritional status, clinical characteristics, histopathology stage, hematological 
profiles, chemical markers, treatment methods, completeness of treatment, and outcome at the end of 
treatment were collected and presented using tables and charts.
Results: Of the 44 subjects, girls (77.3%) were predominant, with a mean age of 2 years old and 
normal nutritional status (59.1%). Patients generally had abdominal mass (97.7%) and most had 
intragonadal GCT (95.5%), with ovarium (76.2%) as the most common location. The most frequent 
GCT histopathology was yolk sac tumor (34.1%), with an Alpha-fetoprotein (AFP) level of >100.000 
(6.8%). Almost all patients (97.7%) had undergone surgery; however, 47% of patients did not complete 
their treatment. At the end of treatment, the majority of patients survived (86.4%).
Conclusions: Germ cell tumor has various clinical characteristics. Understanding these characteristics 
will enable clinicians to make a proper diagnosis and provide immediate management that will lead 
to a better prognosis.
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diagnosis, immediate management, and a 
better prognosis.
Methods
This research design was a cross-sectional 
study using secondary data from the hospital 
information system (SIRS), cancer registry, 
the in-and outpatient medical records. 
The data of pediatric patients with germ 
cell tumor (GCT) was collected in August-
September 2019, including pediatric patients 
who were hospitalized in Dr. Hasan Sadikin 
General Hospital from 2015 to 2018. The data 
collection technique in this study was the total 
sampling method. International Classification 
of Disease (ICD) with code 10 was used 
with the site codes for tumor were ovary 
(C56), testis (C62.9), mediastinum (C37), 
retroperitoneum (C48), and intracranial 
(C49). The exclusion criteria were incomplete 
medical records in histopathology result and 
stage, and patients who did not do the biopsy. 
This study had been approved by the Research 
Ethics Committee of Universitas Padjajaran, 
Bandung No. 809/UN6.KEP/EC/2019 and by 
the Medical Research Ethical Committee of 
Dr. Hasan Sadikin General Hospital, Bandung 
No.LB.02.01/X.2.2.1/12579/2019.
Variables in this study were patient 
identities (age of diagnosis and gender), 
nutritional status, clinical manifestations 
(at the first visit), pathologic features (site, 
staging, and histopathology feature of 
tumor), hematological profiles (hemoglobin 
level, hematocrit level, leukocyte count, 
and thrombocyte count), tumor marker 
such as alpha-fetoprotein (AFP), lactic acid 
dehydrogenase (LDH) and beta-human 
chorionic gonadotropin (β-hCG), methods of 
treatment, completeness of treatment and 
outcome at the end of treatment. To determine 
the hematological profiles and tumor marker 
level, the normal values were used, based on 
gender and age of patients. The stage of GCT 
was based on the Children’s Oncology Group 
(COG).7 Cancer chemotherapy protocol was 
used to determine the completion of the 
treatment.
The data were described and presented in 
the form and table or chart using Microsoft® 
Excel 2016 and IBM® SPSS® version 20.
Results
There were 206 data fulfilled the ICD codes 
10 from the in- and outpatient medical 
records, however, 24 data were missing 
Table 1 Profile and Clinical Manifestation of Pediatric Patients with Germ Cell Tumor in 
 Dr. Hasan Sadikin General Hospital 2015–2018
Characteristic n %
Gender
     Boys






     ≤5 years
     >5–10 years
     10–15 years










     Abdominal mass
     Abdominal pain
     Weight loss
     Pale
     Abdominal tightening
     Intermittent fever
     Menstrual disorder
     Precocious puberty
     Vaginal discharge
     Vaginal bleeding
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and 123 data were not GCT cases such as 
fibroma, cystadenoma mucinosum, and 
rhabdomyosarcoma. Of the 59 GCT data, only 
44 data fulfilled the inclusion criteria, of which 
15 data had incomplete histopathology data or 
staging.
The study showed that the incidence of 
pediatric GCT was mostly aged2 years old 
(13.6%) and aged 17 years old (11.4%). The 
first peak was observed during the first 2 years 
of life both in girls and boys. The second peak 
was observed at the age of 15–17 years both 
in girls and boys. The lowest incidence was 
found at the age of 3 and 10 years old. Most 
of GCT patients were females (77.3%). Among 
the patient under 5 years old, GCT was more 
common in boys than girls (B:G = 2:3). In the 
older patient, GCT was more common in girls 
than boys (B:G = 1:28). Overall, GCT was more 
common in girls than in boys (B:G=1:3.4).
Majority of patients presented with a 
combination of signs and symptoms. Almost all 
of the patients had abdominal mass (97.7%), 
then followed by abdominal pain (34.1%), and 
weight loss as well as pale (both 15.9%). Other 
symptoms included abdominal tightening, 
intermittent fever, menstrual disorder, 
precocious puberty, vaginal discharge, and 
vaginal bleeding were shown in Table 1.
More than half of GCT patients had 
normal nutritional status (59.1%). Severe 
malnutrition was found in 11.4%, mostly aged 
below 10 years old, whereas the moderate 
malnutrition patients were aged between 15–
18 years old as shown in Table 2. Overall, GCT 
was predominantly occurred intragonadal 
(95.5%), with the location of the GCT tumor 
varied with gender as boys had testicular GCT 
and girls had ovarium GCT (94.1%), followed 
by abdominal GCT and vaginal GCT. The 
testicular GCT was most frequent in the age 
group below 5 years, whereas ovarian tumors 
Table 2 Nutritional Status and Tumor Features of Pediatric Patients with Germ Cell Tumor 




Boy Girl ≤5 >5–10 >10–15 >15–18
Nutritional Status
     Severe malnutrition
     Moderate malnutrition
     Normal
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     Testis
     Abdomen






























     Seminoma
     Dysgerminoma
     Germinoma
     Mature teratoma
     Immature teratoma
     Yolk sac tumor
     Choriocarcinoma
     Embryonal carcinoma
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most frequent in the age group 15 to 18 years.
Histologically, the most frequent GCT 
were yolk sac tumor (34.1%), followed by 
dysgerminoma (25%), mature teratoma 
(22.7%), mixed germ cell tumor (9.1%), 
immature teratoma (4.5%), and seminoma 
(2.3%) as well as embryonal carcinoma 
(2.3%). Germinoma and choriocarcinoma 
were not found in this study. In boys, yolk sac 
tumor was predominant, with an age group 
below 5 years old in most of the cases. In girls, 
dysgerminoma was predominant with the 
majority was in the age group between 10 to 
15 years old. Only 20.9% (9 of 44) patients had 
benign GCT. The stage of the GCT in this study 
had stage I (31.8%), stage II (9.1%), stage III 
(31.8%), and stage IV (6.8%) as depicted in 
Table 2.
Almost all patients (97.7%) underwent 
surgery, either surgery only or combined with 
chemotherapy, based on the stage and type 
of histopathology. The majority of benign 
GCT received only surgery (75%), while 
the majority of malignant GCT underwent 
both surgery and chemotherapy (75%). The 
chemotherapy given was the combination of 
bleomycin, cisplatin, and etoposide, known as 
the BEP regiment. 
Only about half of patients completed their 
treatment (52.3%). There were many factors 
that patients did not complete their treatment, 
including died during treatment because of the 
progressivity of the tumor. The other reasons 
for incompletion of treatment are a side effect 
of chemotherapy, sepsis, and loss to follow-
up. However, 1 patient (5%) had died after 
completing the last chemotherapy cycle due 
to his worsening condition. Benign GCT had 
a better outcome than malignant GCT. Benign 
GCT at the age group 15–18 years old had a 
better outcome, whereas in malignant GCT 
the age group below 5 years old had a better 
outcome (Table 3).
Anemia was occurred in 79.5% (35 out 
of 44), which was common in malignancy. 
Furthermore, 68.2% had a low hematocrit 
level. More than half of the patients had 
normal leukocytes (61.4%). No patient had 
low thrombocytes, most of them (56.8%) had 
normal thrombocytes and interestingly, 43.2% 
had high thrombocytes. 
Tumor markers such as alpha-fetoprotein 
(AFP), lactic acid dehydrogenase (LDH), and 
beta-human chorionic gonadotropin (β-hCG) 
were detected in most cases. Overall, the AFP 
level elevated in most patient of which 6.8 % 
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of patients had AFP level up to >100.000. LDH 
was elevated in 11 patients including patients 
with yolk sac tumor, dysgerminoma, mature 
teratoma, and seminoma. β-hCG was elevated 
in patients with dysgerminoma, yolk sac tumor 
and mature teratoma, as shown in Table 4.
At the end of treatment, the majority of 
GCT patients were alive (86.4%). Patients with 
stage I GCT had a better outcome and stage IV 
GCT had a worse outcomes, of whom (33.3%) 
were dead. Seminoma, embryonal carcinoma, 
and mixed GCT had a better outcome in which 
all patients were alive. Immature teratoma has 
the worst outcome in which half of the patients 
were dead (Table 5).
Discussions
The study has described the pediatric patients 
with germ cell tumor (GCT) in Dr. Hasan Sadikin 
General Hospital 2015–2018 of which girls are 
predominant (77.3%). This finding is similar 
Table 4 Hematological Profiles and Tumor Marker of Pediatric Patients with Germ Cell 
Tumor in Dr. Hasan Sadikin General Hospital 2015–2018
Characteristic
Low Normal High
n % n % n %
Hematological Profiles
     Hemoglobin
     Hematocrit
     Leukocyte
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Table 5 End of Treatment Condition of Pediatric Patients with Germ Cell Tumorin Dr. Hasan 




n % n %
Stage
     Benign
     I
     II
     III






















     Seminoma
     Dysgerminoma
     Germinoma
     Mature teratoma
     Immature teratoma
     Yolk sac tumor
     Choriocarcinoma
     Embryonal carcinoma





































Total 38 86.4 6 13.6
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to a study in Turkey8 that girls are common 
(61.4%) among GCT pediatric patients, as 
well as a study in Pakistan9 (52.7%). The 
incidence of pediatric GCT is biphasic; the first 
peak incidence is observed during the first 2 
years of life and the second peak incidence is 
observed at the age of 15–17 years. Our study 
has reported a similar peak mostly which is 
patients aged 2 years old (13.6%) and aged 
17 years old (11.4%) and the previous study 
in Turkey8 shows a similar results, as well as 
another study in the US.10 Interestingly, a study 
in the US has shown the first peak before 1 year 
old. The older the age, the incidence of ovarian 
GCT is increased while the testicular GCT is 
decreased. The striking female predominance 
relates to the high prevalence of ovarian 
tumors in adolescent patients. The majority 
of patients present with a combination of 
signs and symptoms. Almost all patients have 
abdominal mass (97.7%), abdominal pain 
(34.1%), and weight loss as well as paleness. 
The same percentage has been found between 
abdominal pain and abdominal mass, which 
are the primary sign and symptoms in children 
in Turkey (43.6%).8
Interestingly, only one-third of patients 
have malnutrition which is moderate 
malnutrition (27.3%) and severe malnutrition 
(11.4%), similar to a study in India.11 
Furthermore, intragonadal GCT have 
predominantly occurred as also shown in a 
study from Turkey,8 Pakistan,9 and Finland.12 
Mature teratoma is the most common GCT.4,8,12 
For example, yolk sac tumors are common 
(34.1%), followed by dysgerminoma (25%), 
mature teratoma (22.7%). In opposite, 
mature teratoma study is more predominant 
in the US (74.8%).4 Moreover, GCT is mostly 
malignant, with various stages, however, many 
GCT patients have been diagnosed at an early 
stage of the disease. Depends on the stages 
and type of histopathology result, most of the 
patients (97.7%) would undergo surgery, or in 
combination with chemotherapy. 
Tumor markers are important in the 
diagnosis and follow-up. High AFP, LDH,  and 
β-hCG have been detected in 34.5%, 57.7%, 
and 73.9% of the subject, respectively. Most 
of the patients had anemia which is common 
in malignancy. This can be caused by a chronic 
disease process, or due to iron deficiency. 
Furthermore, red cell hypoplasia and 
megaloblastic anemia in malignancies might 
occur.13
Some limitations found in this study are 
among others the retrospective study design 
from a single hospital that has failed to 
demonstrate the correlation between stage 
and condition at the end of treatment. A longer 
period and using multi-centered hospital data, 
the number of respondents can be increased 
and further explored. 
To conclude, germ cell tumor has many 
clinical characteristics, therefore, is important 
to diagnose GCT. Knowing the clinical 
manifestation, histopathology, hematological 
profiles, and chemical marker will help 
clinicians to get a proper diagnosis, immediate 
management, and a better prognosis.
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